Andrés M. Kanner

Active 1990–2025

Also published as
Andres M. Kanner
116
Papers
21,215
Citations
82
h-index
113
i10-index

Citations

Citations per year for Andrés M. Kanner1988: 1 citations1993: 3 citations1994: 6 citations1995: 2 citations1996: 8 citations1997: 7 citations1998: 9 citations1999: 24 citations2000: 35 citations2001: 29 citations2002: 55 citations2003: 76 citations2004: 63 citations2005: 92 citations2006: 118 citations2007: 163 citations2008: 141 citations2009: 151 citations2010: 113 citations2011: 143 citations2012: 168 citations2013: 142 citations2014: 127 citations2015: 131 citations2016: 129 citations2017: 118 citations2018: 121 citations2019: 489 citations2020: 463 citations2021: 442 citations2022: 333 citations2023: 248 citations2024: 475 citations2025: 208 citations2026: 6 citations1989–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,581 citing papers, 28.2% of this breakdownUnited Kingdom: 517 citing papers, 9.2% of this breakdownGermany: 291 citing papers, 5.2% of this breakdownChina: 289 citing papers, 5.2% of this breakdownItaly: 275 citing papers, 4.9% of this breakdownAustralia: 221 citing papers, 3.9% of this breakdownCanada: 220 citing papers, 3.9% of this breakdownFrance: 191 citing papers, 3.4% of this breakdownNetherlands: 165 citing papers, 3% of this breakdownSweden: 118 citing papers, 2.1% of this breakdownIndia: 113 citing papers, 2% of this breakdownSpain: 106 citing papers, 1.9% of this breakdown
0%28.2%Other 27.1%

Fields

  • Medicine71.3%
  • Neuroscience17.3%
  • Biochemistry, Genetics and Molecular Biology5.4%
  • Psychology2.9%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Health Professions0.5%
  • Other2%

Topics

  • Epilepsy research and treatment20.3%
  • Pharmacological Effects and Toxicity Studies12.5%
  • Neuroscience and Neuropharmacology Research6%
  • Psychosomatic Disorders and Their Treatments4.3%
  • EEG and Brain-Computer Interfaces2.6%
  • Pregnancy and Medication Impact2%
  • Other52.3%

Coauthors

All papers

Open in search
  1. Antiseizure Medications for Adults With Epilepsy

    Authors: , - JAMA 2022 cited by 412

  2. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

    Authors: , , , , , , , , , , , - The Lancet Neurology 2013 cited by 831

  3. Neural fragility as an EEG marker of the seizure onset zone

    Authors: , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2021 cited by 163

  4. Management of psychiatric and neurological comorbidities in epilepsy

    Authors: - Nature Reviews Neurology 2016 cited by 440

  5. Source-sink connectivity: a novel interictal EEG marker for seizure localization

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Brain 2022 cited by 102

  6. Psychiatric Comorbidities in People With Epilepsy

    Authors: , , , - Neurology Clinical Practice 2020 cited by 236

  7. Rapid detection of major depression in epilepsy: a multicentre study

    Authors: , , , , , - The Lancet Neurology 2006 cited by 702

  8. The aetiology of psychogenic non‐epileptic seizures: risk factors and comorbidities

    Authors: , , , , , , , , , - Epileptic Disorders 2019 cited by 191

  9. A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 1998 cited by 1,334

  10. Mood Disorders in the Medically Ill: Scientific Review and Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher O’Connor, John M. Petitto, Bruce G. Pollock, Robert G. Robinson, Steven P. Roose, Julia H. Rowland, Yvette I. Sheline, David S. Sheps, Gregory E. Simon, David Spiegel, Albert J. Stunkard, Trey Sunderland, Paul A. Tibbits, William J. Valvo - Biological Psychiatry 2005 cited by 1,074

  11. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

    Authors: - Biological Psychiatry 2003 cited by 522

  12. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy

    Authors: , , , , , , , , - Epilepsia 2021 cited by 79

  13. Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 818

  14. Evidence-based guideline: Management of an unprovoked first seizure in adults

    Authors: , , , , , , , , , , , - Neurology 2015 cited by 335

  15. Laser thermal ablation for mesiotemporal epilepsy: Analysis of ablation volumes and trajectories

    Authors: , , , , , , , , , , , , , , - Epilepsia 2017 cited by 172

  16. Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manisha Holmes, Reetta Kälviäinen, Joon Won Kang, Pavel Klein, Robert C. Knowlton, Kaarkuzhali Babu Krishnamurthy, Ruben Kuzniecky, Patrick Kwan, Daniel H. Lowenstein, Lara Marcuse, Kimford J. Meador, Scott Mintzer, Heath Pardoe, Kristen Park, Patricia Penovich, Rani K. Singh, Ernest Somerville, C. Ákos Szabó, Jerzy P. Szaflarski, Liu Lin Thio, Eugen Trinka, Jorge G. Burneo, and the Human Epilepsy Project - Neurology 2022 cited by 47

  17. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy

    Authors: , , , , , - Epilepsy & Behavior 2003 cited by 448

  18. Cognitive disorders in epilepsy I: Clinical experience, real-world evidence and recommendations

    Authors: , , , - Seizure 2020 cited by 82

  19. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy

    Authors: , , , , , , , , , , , , , , - Epilepsia 2011 cited by 424

  20. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy

    Authors: , , , , , , , , , , , , , , - Neurology 2018 cited by 203

  21. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy

    Authors: , , , , , , , , , , , , , , - Neurology 2018 cited by 130

  22. Depression and epilepsy

    Authors: , - Neurology 2002 cited by 367

  23. Ultra-rare genetic variation in common epilepsies: a case-control sequencing study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brigid M. Regan, Zhong Ren, Ingrid E. Scheffer, Graeme J. Sills, Rhys H. Thomas, Quanli Wang, Bassel Abou‐Khalil, Brian K. Alldredge, Dina Amrom, Eva Andermann, Frédérick Andermann, Jocelyn F. Bautista, Samuel F. Berkovic, Judith Bluvstein, Alex Boro, Gregory D. Cascino, D. Consalvo, Patricia K. Crumrine, Orrin Devinsky, Dennis Dlugos, Michael P. Epstein, Miguel Fiol, Nathan B. Fountain, Jacqueline A. French, Catharine Freyer, Daniel J. Friedman, Eric B. Geller, Tracy A. Glauser, Simon Glynn, Kevin F. Haas, Sheryl R. Haut, Jean Hayward, Sandra L. Helmers, Sucheta M. Joshi, Andrés M. Kanner, Heidi E. Kirsch, Robert C. Knowlton, Eric H. Kossoff, Rachel Kuperman, Ruben Kuzniecky, Daniel H. Lowenstein, Paul Motika, Edward J. Novotny, Ruth Ottman, Juliann Paolicchi, Jack M. Parent, Kristen Park, Annapurna Poduri, Lynette G. Sadleir, Ingrid E. Scheffer, Renée A. Shellhaas, Elliott H. Sherr, Jerry J. Shih, Shlomo Shinnar, Rani K. Singh, Joseph Sirven, Michael C. Smith, Joseph Sullivan, Liu Lin Thio, Anu Venkat, Eileen P.G. Vining, Gretchen K. Von Allmen, Judith Weisenberg, Peter Widdess‐Walsh, Melodie R. Winawer - The Lancet Neurology 2017 cited by 234

  24. Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years

    Authors: , , , , , , , , , , , - Epilepsy & Behavior 2013 cited by 176